Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 03/11/19981 min de lecture
Implantation or Injectable Dosage Form New Animal Drugs; Hyaluronate Sodium
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Anika Therapeutics, Inc. The supplemental NADA provides for equine use of hyaluronate sodium injection containing 11 milligrams hyaluronate sodium per milliliter (mg/mL) rather than the currently approved 10 mg/mL.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →